[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 72 of about 72
25. Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger M, Dupuy C: Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocr Relat Cancer; 2010 Mar;17(1):27-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To date, in the thyroid gland, only DUOX1/2 NOX systems have been described.
  • [MeSH-major] Adenocarcinoma, Follicular / enzymology. Adenoma / enzymology. Carcinoma / enzymology. Carcinoma, Papillary / enzymology. NADPH Oxidase / biosynthesis. Neoplasm Proteins / biosynthesis. Reactive Oxygen Species / metabolism. Thyroid Gland / enzymology. Thyroid Neoplasms / enzymology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • Hazardous Substances Data Bank. HYDROGEN PEROXIDE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19779036.001).
  • [ISSN] 1479-6821
  • [Journal-full-title] Endocrine-related cancer
  • [ISO-abbreviation] Endocr. Relat. Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / RNA, Small Interfering; 0 / Reactive Oxygen Species; 9002-71-5 / Thyrotropin; BBX060AN9V / Hydrogen Peroxide; EC 1.6.3.- / NOX4 protein, human; EC 1.6.3.1 / CYBA protein, human; EC 1.6.3.1 / DUOX1 protein, human; EC 1.6.3.1 / NADPH Oxidase
  •  go-up   go-down


26. Zembowicz A, Garcia CF, Tannous ZS, Mihm MC, Koerner F, Pilch BZ: Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas. Am J Surg Pathol; 2005 Oct;29(10):1330-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas.
  • Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is an underrecognized low-grade carcinoma with predilection to the eyelid.
  • The series provides histologic evidence for a multistage progression of noninvasive sweat gland neuroendocrine carcinoma to EMPSGC and then to mucinous carcinoma of the eyelid.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Sweat Gland Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16160476.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


27. Nakano S, Shomura H, Akabane H, Inagaki M, Yanagida N: [Two cases of gastric endocrine cell carcinoma]. Gan To Kagaku Ryoho; 2010 Nov;37(12):2505-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Two cases of gastric endocrine cell carcinoma].
  • Gastric endocrine cell carcinoma is rare and associated with a poor prognosis.
  • The first case was a man in his sixties with gastric endocrine cell carcinoma, of which a clinical finding was T2N1M0H1 (Stage IV).
  • But the tumor was re-grown and the patient died twenty months after diagnosis.
  • The second case was a man in his seventies with gastric endocrine cell carcinoma, of which a clinical finding was T3N1M0H0P0, Stage IIIa, underwent total gastrectomy.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Aged. Antineoplastic Agents / administration & dosage. Antineoplastic Agents, Phytogenic / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Camptothecin / administration & dosage. Camptothecin / analogs & derivatives. Cisplatin / administration & dosage. Drug Combinations. Humans. Male. Middle Aged. Oxonic Acid / administration & dosage. Tegafur / administration & dosage

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21224621.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Phytogenic; 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; 7673326042 / irinotecan; Q20Q21Q62J / Cisplatin; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


28. Calzolari F, Sartori PV, Talarico C, Parmeggiani D, Beretta E, Pezzullo L, Bovo G, Sperlongano P, Monacelli M, Lucchini R, Misso C, Gurrado A, D'Ajello M, Uggeri F, Puxeddu E, Nasi P, Testini M, Rosato L, Barbarisio A, Avenia N: Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study. Anticancer Res; 2008 Sep-Oct;28(5B):2885-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to detect which neoplasms metastasize most often to the thyroid gland, their clinical features and treatment options.
  • A long delay between the primary tumor and the recurrence warrants surgery and total thyroidectomy seems to be the treatment of choice because of the multifocality of metastasis to the thyroid gland.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / secondary. Adenocarcinoma / surgery. Adult. Aged. Biopsy, Fine-Needle. Breast Neoplasms / pathology. Carcinoma, Renal Cell / pathology. Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Colonic Neoplasms / pathology. Female. Follow-Up Studies. Humans. Kidney Neoplasms / pathology. Lung Neoplasms / pathology. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031929.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Greece
  •  go-up   go-down


6
Advertisement
4. Kocjan G: Fine needle aspiration cytology of the pancreas: a guide to the diagnostic approach. Coll Antropol; 2010 Jun;34(2):749-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Despite the advances in the imaging techniques, management options for patients are limited and a malignant diagnosis of solid lesions still carries a high mortality rate.
  • The importance of a cytopathologist in preoperative diagnosis, as a member of the multidisciplinary team, is exemplified in the management of patients with neoplastic cysts.
  • A cytological diagnosis can be obtained with minimally invasive techniques that utilize CT US or EUS.
  • [MeSH-minor] Adenocarcinoma / pathology. Cystadenoma / pathology. Endocrine Gland Neoplasms / pathology. Humans. Teratoma / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698166.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Croatia
  • [Number-of-references] 62
  •  go-up   go-down


65. Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andrén O, Bill-Axelson A, Bratt O, Damber JE, Hellström K, Hellström M, Holmberg E, Holmberg L, Hugosson J, Johansson JE, Petterson B, Törnblom M, Widmark A, Stattin P: Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol; 2007;41(6):456-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment.
  • MATERIAL AND METHODS: Between 1996 and 2005, all new cases of adenocarcinoma of the prostate gland were intended to be registered in the National Prostate Cancer Register (NPCR).
  • This register contains information on diagnosing unit, date of diagnosis, cause of diagnosis, tumor grade, tumor stage according to the TNM classification in force, serum prostate-specific antigen (PSA) levels at diagnosis and primary treatment given within the first 6 months after diagnosis.
  • During the study period there was a considerable decrease in median age at the time of diagnosis, a stage migration towards smaller tumors, a decrease in median serum PSA values at diagnosis, a decrease in the age-standardized incidence rate of men diagnosed with distant metastases or with a PSA level of > 100 ng/ml at diagnosis and an increase in the proportion of tumors with Gleason score <6.
  • Relatively large geographical differences in the median age at diagnosis and the age-standardized incidence of cases with category T1c tumors were observed.
  • In men with localized tumors and a PSA level of <20 ng/ml at diagnosis, expectant treatment was more commonly used in those aged > or =75 years than in those aged <75 years.
  • Also, the pattern of endocrine treatment varied in different parts of Sweden.
  • The patterns of diagnosis and treatment of prostate cancer vary considerably in different parts of Sweden.
  • The NPCR continues to be an important source for research, epidemiological surveillance of the incidence, diagnosis and treatment of prostate cancer.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / therapy


66. Norimura D, Mizuta Y, Oohara H, Okamoto K, Hayashi H, Matuo T, Nakagoe T, Isomoto H, Shikuwa S, Kohno S: [A case of endocrine carcinoma of the sigmoid colon]. Nihon Shokakibyo Gakkai Zasshi; 2008 Feb;105(2):228-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of endocrine carcinoma of the sigmoid colon].
  • We report a case of endocrine carcinoma of the sigmoid colon.
  • He was given a diagnosis of the poorly differentiated adenocarcinoma of the colon, and underwent sigmoidectomy with dissection of the lymph nodes.
  • Histological and immunohistochemical examinations of the resected specimen revealed endocrine carcinoma.
  • Endocrine carcinoma of the colon is rare, and the prognosis is very poor.
  • [MeSH-major] Endocrine Gland Neoplasms / pathology. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18250594.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


67. Hines OJ, Reber HA: Pancreatic surgery. Curr Opin Gastroenterol; 2009 Sep;25(5):460-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RECENT FINDINGS: Obesity is an important risk factor for many diseases of the pancreas, including pancreatic adenocarcinoma.
  • Recent evidence suggests that obese patients with pancreatic cancer appear to have more advanced disease at the time of diagnosis and a worse outcome following resection.
  • Resection of pancreatic endocrine neoplasms is often appropriate, even in the face of metastatic disease.
  • For those dedicated to the study and treatment of this gland, several new advances help the clinician with treatment decisions.

  • MedlinePlus Health Information. consumer health - Pancreatic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19550315.001).
  • [ISSN] 1531-7056
  • [Journal-full-title] Current opinion in gastroenterology
  • [ISO-abbreviation] Curr. Opin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 22
  •  go-up   go-down


68. Lachinski AJ, Stefaniak T, Kobiela J, Connor S, Gruca Z, Sledzinski Z: New prognostic scales LAST-1 and LAST-2: supporting prediction and staging of thyroid cancer. World J Surg; 2006 Mar;30(3):309-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Epidemiologically, thyroid gland tumors are lesions of the highest importance among endocrine tumors in humans.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Carcinoma, Papillary / pathology. Neoplasm Staging / methods. Thyroid Neoplasms / pathology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 1999 Sep;84(9):3235-40 [10487693.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Nov;82(11):3684-91 [9360526.001]
  • [Cites] Hum Genet. 1996 Mar;97(3):299-303 [8786068.001]
  • [Cites] Eur J Endocrinol. 2004 Sep;151(3):367-74 [15362967.001]
  • [Cites] Endocr Pathol. 2004 Winter;15(4):319-27 [15681856.001]
  • [Cites] Cancer. 2004 Mar 15;100(6):1123-9 [15022277.001]
  • [Cites] Mod Pathol. 2000 May;13(5):562-9 [10824929.001]
  • [Cites] Trends Mol Med. 2004 Jul;10(7):351-7 [15242684.001]
  • [Cites] Endocr Pathol. 2002 Winter;13(4):271-88 [12665646.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15044-9 [11752453.001]
  • [Cites] Eur J Cancer. 1979 Aug;15(8):1033-41 [510341.001]
  • [Cites] Eur J Cancer. 2001 Dec;37(18):2470-4 [11720845.001]
  • [Cites] Laryngoscope. 2004 Mar;114(3):393-402 [15091208.001]
  • [Cites] Tokai J Exp Clin Med. 2002 Aug;27(2):43-9 [12472169.001]
  • [Cites] Thyroid. 2001 Oct;11(10):953-7 [11716043.001]
  • [Cites] Am J Pathol. 1998 Jun;152(6):1407-13 [9626044.001]
  • [Cites] Anticancer Res. 2003 Sep-Oct;23(5A):3819-24 [14666683.001]
  • [Cites] Ann Surg. 2003 Feb;237(2):227-34 [12560781.001]
  • [Cites] Pathol Res Pract. 2003;199(6):399-404 [12924440.001]
  • [Cites] World J Surg. 2002 Aug;26(8):879-85 [12016468.001]
  • [Cites] Thyroid. 2003 Oct;13(10):949-58 [14611704.001]
  • [Cites] Humangenetik. 1972;15(4):349-53 [4117698.001]
  • [Cites] Cancer Genet Cytogenet. 1991 Apr;52(2):157-64 [2021917.001]
  • [Cites] Lab Invest. 2004 May;84(5):649-57 [15048133.001]
  • [Cites] Eur J Surg Oncol. 2004 Feb;30(1):58-62 [14736524.001]
  • [Cites] Am Surg. 1995 Feb;61(2):151-5 [7856976.001]
  • [Cites] Genes Chromosomes Cancer. 1999 Dec;26(4):322-8 [10534767.001]
  • [Cites] Wiad Lek. 2004;57(7-8):306-10 [15631182.001]
  • [Cites] Endocr Pathol. 2003 Fall;14(3):213-19 [14586066.001]
  • [Cites] Surgery. 2003 Dec;134(6):1043-7; discussion 1047-8 [14668739.001]
  • [Cites] Surgery. 2002 Apr;131(4):443-9 [11935135.001]
  • [Cites] J Clin Invest. 2004 Apr;113(8):1234-42 [15085203.001]
  • [Cites] Am J Surg Pathol. 2004 Jan;28(1):101-6 [14707871.001]
  • [Cites] Cancer Res. 2003 Apr 1;63(7):1454-7 [12670889.001]
  • [Cites] Thyroid. 2001 Dec;11(12):1135-40 [12186500.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Sep;86(9):4268-72 [11549660.001]
  • [Cites] Ann Genet. 1984;27(3):134-47 [6095729.001]
  • [Cites] Tumori. 2003 Sep-Oct;89(5):517-9 [14870775.001]
  • [Cites] Surgery. 1988 Dec;104(6):947-53 [3194846.001]
  • [Cites] Br J Cancer. 2004 Jan 26;90(2):492-6 [14735198.001]
  • [Cites] Gut. 2004 Dec;53(12):1860-5 [15542529.001]
  • [Cites] J Natl Cancer Inst. 1994 Nov 2;86(21):1600-8 [7932824.001]
  • [Cites] Curr Treat Options Oncol. 2004 Aug;5(4):315-25 [15233908.001]
  • [Cites] J Exp Clin Cancer Res. 2002 Mar;21(1):79-86 [12071534.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Feb;83(2):525-30 [9467569.001]
  • [Cites] Onkologie. 2001 Dec;24(6):561-8 [11799311.001]
  • [Cites] Neoplasma. 2003;50(1):26-30 [12687275.001]
  • [Cites] Cancer Lett. 2004 Jul 16;210(2):151-7 [15183530.001]
  • [Cites] Laryngoscope. 2005 Apr;115(4):661-7 [15805877.001]
  • [Cites] Ear Nose Throat J. 2002 Dec;81(12):856-63 [12516384.001]
  • [Cites] Ann Surg Oncol. 2005 Jan;12(1):81-9 [15827782.001]
  • (PMID = 16479347.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


69. Badger SA, Brant JL, Jones C, McClements J, Loughrey MB, Taylor MA, Diamond T, McKie LD: The role of surgery for pancreatic cancer: a 12-year review of patient outcome. Ulster Med J; 2010 May;79(2):70-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Survival was worse with adenocarcinoma compared to all other pathologies (p=0.013), while periampullary tumours had a better prognosis compared to other locations (p=0.019).
  • [MeSH-major] Adenocarcinoma / surgery. Endocrine Gland Neoplasms / surgery. Pancreatectomy. Pancreatic Neoplasms / surgery

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2006 Aug 21;95(4):445-9 [16880789.001]
  • [Cites] Br J Surg. 2004 Nov;91(11):1410-27 [15499648.001]
  • [Cites] Pancreas. 2006 Oct;33(3):240-5 [17003644.001]
  • [Cites] Tumori. 2006 Sep-Oct;92(5):416-22 [17168435.001]
  • [Cites] Ann Surg. 2007 May;245(5):777-83 [17457171.001]
  • [Cites] Ann Surg. 2007 Jul;246(1):52-60 [17592291.001]
  • [Cites] Eur J Surg Oncol. 2007 Sep;33(7):892-7 [17398060.001]
  • [Cites] Nat Clin Pract Oncol. 2007 Sep;4(9):526-35 [17728711.001]
  • [Cites] Ann Surg. 2008 Jul;248(1):97-103 [18580212.001]
  • [Cites] Annu Rev Med. 2009;60:405-15 [18759554.001]
  • [Cites] J Surg Oncol. 2000 Apr;73(4):212-8 [10797334.001]
  • [Cites] Am J Surg. 2000 Jul;180(1):13-7 [11036132.001]
  • [Cites] Ann Surg. 2001 Dec;234(6):758-68 [11729382.001]
  • [Cites] Eur J Cancer. 2004 Mar;40(4):549-58 [14962722.001]
  • [Cites] Lancet. 2004 Mar 27;363(9414):1049-57 [15051286.001]
  • [Cites] Am Surg. 2004 Mar;70(3):235-40; discussion 240 [15055847.001]
  • [Cites] N Engl J Med. 1979 Dec 20;301(25):1364-9 [503167.001]
  • [Cites] Aust N Z J Surg. 1984 Feb;54(1):53-8 [6586168.001]
  • [Cites] Am J Surg. 1986 Jan;151(1):141-9 [3946745.001]
  • [Cites] Ann Surg. 1986 Oct;204(4):411-8 [3767476.001]
  • [Cites] Gastroenterology. 1994 Jul;107(1):219-30 [8020665.001]
  • [Cites] Cancer. 1995 Apr 15;75(8):2069-76 [7697596.001]
  • [Cites] Ann Surg. 1997 Sep;226(3):248-57; discussion 257-60 [9339931.001]
  • [Cites] Am J Clin Pathol. 1999 Mar;111(3):304-7 [10078104.001]
  • [Cites] Br J Surg. 2006 Oct;93(10):1232-7 [16804874.001]
  • (PMID = 21116422.001).
  • [ISSN] 0041-6193
  • [Journal-full-title] The Ulster medical journal
  • [ISO-abbreviation] Ulster Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Northern Ireland
  • [Other-IDs] NLM/ PMC2993146
  • [Keywords] NOTNLM ; Whipple's procedure / pancreatic cancer / survival
  •  go-up   go-down


70. Jiang X, Abiatari I, Kong B, Erkan M, De Oliveira T, Giese NA, Michalski CW, Friess H, Kleeff J: Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer. Pancreatology; 2009;9(1-2):165-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.
  • AIMS: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticins have been identified as tissue-specific angiogenic factors.
  • RESULTS: QRT-PCR analysis in bulk tissues of normal pancreas, chronic pancreatitis and pancreatic ductal adenocarcinoma showed no significant difference of PK1 mRNA levels, whereas PK2 mRNA was barely detectable.
  • [MeSH-major] Islets of Langerhans / metabolism. Pancreas / metabolism. Pancreatic Neoplasms / metabolism. Vascular Endothelial Growth Factor, Endocrine-Gland-Derived / biosynthesis

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • Genetic Alliance. consumer health - Pancreatic cancer 1.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel and IAP.
  • (PMID = 19077468.001).
  • [ISSN] 1424-3911
  • [Journal-full-title] Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
  • [ISO-abbreviation] Pancreatology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Gastrointestinal Hormones; 0 / Neuropeptides; 0 / PROK2 protein, human; 0 / PROKR1 protein, human; 0 / PROKR2 protein, human; 0 / RNA, Messenger; 0 / Receptors, G-Protein-Coupled; 0 / Receptors, Peptide; 0 / Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
  •  go-up   go-down


71. Albores-Saavedra J, Wu J: The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol; 2006;17(1):1-18
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article provides an overview of the 15 histologic variants of papillary thyroid carcinoma listed by the 2004 World Health Organization (WHO) monograph on endocrine tumors.
  • The histologic features, differential diagnosis, and clinical course of each variant are discussed in some detail.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adenoma / diagnosis. Cell Nucleus / pathology. Diagnosis, Differential. Hashimoto Disease / diagnosis. Humans. Hyperplasia / diagnosis. Thyroid Gland / pathology. World Health Organization

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 1960 Jan-Feb;9:86-97 [14400378.001]
  • [Cites] Mod Pathol. 2000 Jul;13(7):742-6 [10912933.001]
  • [Cites] Am J Surg Pathol. 1995 Jul;19(7):810-4 [7793479.001]
  • [Cites] Am J Clin Pathol. 1988 Feb;89(2):264-7 [3341287.001]
  • [Cites] Virchows Arch. 1996 Nov;429(4-5):213-9 [8972756.001]
  • [Cites] Am J Clin Pathol. 2002 Jan;117(1):19-21 [11789725.001]
  • [Cites] Am J Surg Pathol. 2004 Oct;28(10):1336-40 [15371949.001]
  • [Cites] Hum Pathol. 2005 Jun;36(6):694-7 [16021577.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2002 Dec;10(4):332-8 [12613443.001]
  • [Cites] Am J Clin Pathol. 1986 Jan;85(1):77-80 [3940424.001]
  • [Cites] Hum Pathol. 1995 Oct;26(10):1099-108 [7557943.001]
  • [Cites] Oncogene. 2003 Jul 17;22(29):4578-80 [12881714.001]
  • [Cites] Pathol Int. 2002 Jan;52(1):54-8 [11940207.001]
  • [Cites] Hum Pathol. 1990 Nov;21(11):1151-5 [2227923.001]
  • [Cites] Histopathology. 1994 Dec;25(6):549-61 [7698732.001]
  • [Cites] Cancer. 1971 Sep;28(3):763-74 [5096937.001]
  • [Cites] Ann Diagn Pathol. 2003 Dec;7(6):348-53 [15018117.001]
  • [Cites] World J Surg. 1998 Jul;22(7):738-42; discussion 743 [9606291.001]
  • [Cites] Cancer. 1997 Sep 15;80(6):1110-6 [9305712.001]
  • [Cites] Diagn Cytopathol. 1998 Feb;18(2):93-7 [9484636.001]
  • [Cites] Am J Surg Pathol. 1988 Jan;12(1):22-7 [3337337.001]
  • [Cites] Cancer. 1994 Jan 15;73(2):416-23 [8293409.001]
  • [Cites] Hum Pathol. 1994 Feb;25(2):192-7 [8119720.001]
  • [Cites] Mod Pathol. 1999 Apr;12(4):400-11 [10229505.001]
  • [Cites] Virchows Arch. 1997 May;430(5):397-405 [9174630.001]
  • [Cites] Cancer. 1998 Feb 15;82(4):740-53 [9477108.001]
  • [Cites] Endocr Pathol. 1997 Winter;8(4):283-292 [12114789.001]
  • [Cites] Am J Clin Pathol. 2001 Nov;116(5):696-702 [11710686.001]
  • [Cites] Anticancer Res. 1998 Jul-Aug;18(4A):2637-41 [9703921.001]
  • [Cites] Am Surg. 1998 Apr;64(4):307-11 [9544139.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Feb;85(2):878-82 [10690905.001]
  • [Cites] Mod Pathol. 1995 May;8(4):366-70 [7567932.001]
  • [Cites] Cleve Clin Q. 1976 WINTER;43(4):207-15 [1000814.001]
  • [Cites] Cancer. 1990 Mar 1;65(5):1173-9 [2302665.001]
  • [Cites] Am J Surg Pathol. 1989 Dec;13(12):1041-9 [2490923.001]
  • [Cites] Am J Surg Pathol. 1996 Aug;20(8):964-74 [8712296.001]
  • [Cites] Cancer. 2003 Jul 1;98(1):31-40 [12833452.001]
  • [Cites] Cancer Res. 2003 Apr 1;63(7):1454-7 [12670889.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):48-57 [15272279.001]
  • [Cites] Am J Surg Pathol. 1995 Oct;19(10):1209-15 [7573680.001]
  • [Cites] Semin Diagn Pathol. 1985 May;2(2):90-100 [3843693.001]
  • [Cites] J Clin Endocrinol Metab. 1948 Sep;8(9):749-61 [18880943.001]
  • [Cites] Am J Surg Pathol. 1985 Oct;9(10):705-22 [4061729.001]
  • [Cites] Endocr Pathol. 2002 Winter;13(4):301-11 [12665648.001]
  • [Cites] Hum Pathol. 1997 Jan;28(1):47-53 [9013831.001]
  • [Cites] Histopathology. 2004 Nov;45(5):493-500 [15500653.001]
  • [Cites] Am J Surg Pathol. 1984 Mar;8(3):187-92 [6703194.001]
  • [Cites] Am J Surg Pathol. 2001 Dec;25(12):1485-92 [11717537.001]
  • [Cites] Histopathology. 2002 Oct;41(4):357-62 [12383219.001]
  • [Cites] Am J Surg Pathol. 1977 Jun;1(2):123-30 [602974.001]
  • [Cites] Endocr Pathol. 2004 Winter;15(4):297-305 [15681853.001]
  • [Cites] Am J Surg Pathol. 2001 Dec;25(12):1478-84 [11717536.001]
  • [Cites] J Natl Cancer Inst. 2003 Apr 16;95(8):625-7 [12697856.001]
  • [Cites] Virchows Arch. 2002 Apr;440(4):418-24 [11956824.001]
  • [Cites] Pathol Int. 1996 Dec;46(12):939-46 [9110345.001]
  • [Cites] Hum Pathol. 1991 Dec;22(12):1195-205 [1748427.001]
  • [Cites] Arch Pathol Lab Med. 1996 Apr;120(4):397-8 [8619755.001]
  • [Cites] Int J Surg Pathol. 2003 Oct;11(4):249-51 [14615819.001]
  • [Cites] Am J Surg Pathol. 1986 Oct;10(10):672-9 [3766846.001]
  • [Cites] Laryngoscope. 1997 Jan;107(1):95-100 [9001272.001]
  • [Cites] Acta Pathol Jpn. 1993 Jul-Aug;43(7-8):428-33 [8372687.001]
  • [Cites] Am J Surg Pathol. 1983 Dec;7(8):797-807 [6660352.001]
  • [Cites] Cancer. 1966 Aug;19(8):1039-52 [5916581.001]
  • (PMID = 16760576.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 68
  •  go-up   go-down


72. Enomoto K, Sakurai K, Amano S, Shiono M: [A case of malignant lymphoma that seemed to be thyroid cancer lymph nodes recurrence]. Gan To Kagaku Ryoho; 2008 Nov;35(12):2213-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A tumor in the survival thyroid gland was confirmed in 1995.
  • In February 2007, the tumor of the survival thyroid gland was enlarged.
  • Histopathology diagnosis showed it to be of a papillary adenocarcinoma of thyroid recurrence.
  • The diagnosis was malignant lymphoma.






Advertisement